Optimizing HDAC inhibitors to enhance HDR-associated CRISPR-Cas9 gene editing efficiency in vivo and in vitro
Gene editing by CRISPR-Cas9 via homology-directed repair (HDR) offers precise and desirable modifications, but its low efficiency remains a challenge due to the dominance of the non-homologous end joining (NHEJ) pathway in DNA repair. To identify compounds that improve HDR-associated gene editing ef...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Heliyon |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025013520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Gene editing by CRISPR-Cas9 via homology-directed repair (HDR) offers precise and desirable modifications, but its low efficiency remains a challenge due to the dominance of the non-homologous end joining (NHEJ) pathway in DNA repair. To identify compounds that improve HDR-associated gene editing efficiency, we established a high-throughput screening system capable of detecting HDR events and assessing cell viability simultaneously, excluding drugs with severe cytotoxicity. We screened 2485 compounds from a clinical collection library and identified several histone deacetylase inhibitors that significantly enhance HDR efficiency. Tacedinaline and entinostat exhibited the high efficiency in promoting HDR-associated gene editing among them. Notably, entinostat treatment led to a significant increase in HDR-associated gene editing in vivo. Our study provides optimized HDAC inhibitor conditions for high-efficiency HDR-associated gene editing both in vivo and in vitro. |
|---|---|
| ISSN: | 2405-8440 |